Background: The gene encoding the hepatotrophic factor Augmenter of Liver Regeneration (ALR) has recently been cloned in the rat. The availability of the mouse form of ALR would allow the analysis of the role of this factor in the physiology of liver and other organs, while the identification of the human homolog would allow the transfer of the great wealth of information that has been generated in animal models to clinically oriented pilot trials, and eventually the therapeutic application of this information. Materials and Methods: Standard molecular biology approaches have been used to determine the genomic structure of the ALR gene in the mouse, and to characterize the ALR transcript and its protein product. The human ALR cDNA was also isolated and the amino acid sequence of the human gene product deduced. The mapping of mouse and human ALR genes on mouse and human chromosomes was then completed.
INTRODUCTION
The extraordinary regenerative capacity of mammalian liver has long motivated investigations of factors involved in this aspect of multicellularity. One of the latest hepatotrophic factors described, named augmenter of liver regeneration (ALR), was purified from the cytosol of weanling rat livers (1) . This factor, originally called hepatic regenerative stimulation substance (HSS), augments the cell proliferative response following hepatectomy in rats (2) and dogs (3) .
The search for ALR began in 1931, when McJunkin and Breuhaus (4) reported that the modest regeneration following a limited (30-45%) hepatectomy in rats was amplified by an intraperitoneal postoperative injection of rat 98 Molecular Medicine, Volume 2, Number 1, January 1996 liver homogenate. This regeneration augmenting effect was shown by Teir and Ravanti (5) , and Blomquist (6) to require the presence of hyperplasia in the livers used for homogenate source. However, a requisite co-condition was a preexisting commitment to hyperplasia in the liver of the injected test animal. The same two requirements characterized the hepatic stimulatory substance found by LaBreque and Pesch (7) in regenerating adult and weanling rat liver cytosol. A heat-stable moiety of the cytosol was retained through several hundred thousand times purification (1, 8, 9) , and ultimately by the peptide product of the ALR gene (10) .
Because ALR has no effect on either the resting intact liver, or on cultured hepatocytes (1) , its identification through a succession of purification steps depended on two in vivo assays: an insensitive minimal hepatectomy model, in which ALR activity in an injected test substance was identified when it caused a greater than normal regeneration response to 30-40% hepatectomy in rats and dogs (7, 8, 9) , or, alternatively, with a canine Eck fistula model (1 1) . With the Eck fistula assay, intraportally injected ALR produced a proliferative response beyond the low-grade hepatocyte hyperplasia produced with portacaval shunt in dogs. In addition, the ALR prevented the acute hepatocyte atrophy and dramatic organelle disruption that is produced by this operation (8, 9, 11) . The triad of mitotic response, organelle preservation, and prevention of atrophy in the Eck fistula model has successively defined a family of "hepatotrophic" agents beginning with insulin (12) and crude hepatic cytosol (11) that ultimately included recombinant ALR (10) , three conventional growth factors (HGF, IGF, TGFa) (1), two cell directed immunosuppressants (cyclosporine [131 and tacrolimus [14] ), and the immunophilin FKBP12 (15) . Why these diverse molecules all have essentially the same effects is an unresolved question.
Although the cDNA coding for the rat ALR has recently been isolated and a biologically active recombinant peptide produced (10), virtually nothing is known about the cellular physiology of ALR. One possible suggestion comes from the proven 50% homology that ALR protein shows to the product of the dual function nuclear Saccharomyces cerevisiae gene ERV-1, which is essential for oxidative phosphorylation, vegetative growth and life of the yeast (16 We report here the complete (i.e., genomic) nucleotide sequence of the mouse ALR gene, as well as its mRNA transcript. We also report on ALR mRNA expression and its product presence in mouse tissues. In addition, we report the sequence of human ALR, and its comparison with the rat and mouse sequences. The human gene was found to map to human chromosome 16. The mouse gene is located on a portion of chromosome 17, which has a documented homology to the human chromosome 16 , and where the Tlt region has also been mapped (17, 18) . These findings imply a role for the highly conserved ALR gene, not only as a liver growth factor, but in a wide range of other biological processes as well.
MATERIALS AND METHODS Cloning of Mouse ALR Gene
A (C57B1/6 x CBA)F1 mouse genomic library in A FIX II vector (Stratagene, La Jolla, CA, U.S.A.) was screened with a rat ALR cDNA probe (i.e., 1.2-kb EcoRI fragment [10] ). Phage plaques, plated at approximately 50,000 pfu/plate, were screened on duplicate filters by hybridization against a 32P-labeled rat ALR cDNA probe. Radioactive probes were generated by random priming using a Multiprime labeling kit (Amersham, Arlington Heights, IL, U.S.A.). Hybridization was performed according to Maniatis et (Fig. 2) (24) .
Expression of Mouse ALR
The structure of the mouse ALR transcripts was analyzed by 5' and 3' RACE. As expected, rat and mouse cDNAs were found to be highly homologous in both nucleotide sequence (90% identity) and putative translation product (96% identity). The human cDNA was also found to be very similar to the rodent cDNAs, particularly at the protein level (Fig. 3) . Polyadenylation of human and mouse mRNAs appears to occur at the same position as that seen for the rat mRNA. The 5' RACE amplification generated a fragment starting at position 49 of the rat cDNA. Remarkably, a 166-bp portion of mouse cDNA sequence, corresponding to position 82-248 of the rat cDNA, was found consistently to be missing both in RACE protocols and in amplifications performed with conventional primers (Fig. 2) . The exon/ intron boundaries of this mouse intron, unlike the human and rat sequences, were found not to contain canonical AG_GT motifs. By Northern blot hybridization of the ALR cDNA as probe to a panel of poly-A+ RNAs from mouse tissues, a 1.3-to 1.4-kb band was found in mRNA from all mouse tissues examined, but liver, and particularly testis, yielded the strongest signal (Fig. 4) . By sequencing, ALR transcripts from both liver and testis have the same structure. The ALR transcript in the liver was found not to show a demonstrable change in quantity during the tissue regeneration that follows partial hepatectomy (data not shown). From this analysis of the gene sequence and transcript size, it was not possible to determine the ALR protein's size and structure. Therefore, we attempted to determine directly the precise size and structure of the ALR protein by Western blot analysis with a rabbit antiserum against a putative N-terminal peptide of the rat protein.
We found this serum to recognize a 23-kD band in all tissue examined (Fig. 5) swered, including the size and amino acid sequence of the peptide and its physiologic function. Rat ALR cDNA was originally described as having only one ATG translation start codon in the correct reading frame (10) . Later, a correction in the noncoding cDNA sequence generated a longer open reading frame containing two additional ATG codons upstream from the original ATG (26) . The same three in-frame ATG codons are also present in the human ALR cDNA, while in the mouse the observed 166-bp deletion removes both additional ATGs. However, while the absence of this segment of the mouse gene was observed consistently, we cannot exclude that this absence could be an artifact of the amplification procedure that is caused by the somewhat peculiar sequence of the region, particularly in view of its unusual exon/intron junction.
If we ignore the deletion, the genomic ALR sequence reveals an even longer open reading frame, containing two additional ATG codons. Given the size of the mouse ALR transcript, 1.3-1.4 kb, only 100-200 bases of upstream sequence can be transcribed in addition to the known sequence. If the TATA box of the ALR promoter is located in the position indicated in Fig. 2 , one or more additional introns must be postulated to account for the size of the mature transcript. In addition, the faint 2.7-to 2.8-kb band visible in the Northern blot in Fig. 4 could indicate the size of the primary ALR transcript, placing the transcription initiation site in close proximity to the putative TATA box. Unfortunately we have not yet been able to obtain a longer 5' RACE product, most likely because of the presence of the G/C rich content of this region.
The size of the ALR protein determined by Western blot argues for a translation product larger than the one previously postulated (10 (Fig. 7) is both surprising and intriguing. No other protein is known to contain only one-half of a zinc finger motif, and it will be interesting to find out the relation of this finding to ALR function. Transfection studies, and possibly the generation of chimeric knock-out animals, will be needed to test any explanatory hypotheses. If, as suspected, the gene is critical to cell function, the inability to achieve survival with its deletion will be similar to that encountered with hepatocyte growth factor (HGF) (30, 31) . Remarkably, HGF is thought to mediate a motogenic, mitogenic, and morphogenetic signal exchange between mesenchyme and epithelia during mammalian development (32) . We suspect that the same is true with ALR, and that the family of eight liver augmenters delineated with the Eck fistula model, have a commonality of end points. The regulation of 5' cap function rate of translation, and thereby cell growth, has been shown for insulin and other growth factors (33) .
Finally, it is worthwhile to note that, from the analysis of backcross mice, the ALR gene maps to the Tlt region of chromosome 17 of the mouse (17, 18) . This chromosomal region is marked by a conventional dominant mutant gene, called T, and by a series of complicated recessive t-mutants that affect large regions of the chromosome. The t-alleles are either lethal, or male sterile, when homozygous. In one of the truly bizarre features on this genetic system, male mice of ti+ genotype often transmit their mutant t-alleles to many more than the expected 50% of their offspring.
Apparently, spermatozoa carrying a t-mutated haplotype interfere with the viability of the spermatozoa carrying the + chromosome, leading to increased transmission of the t-allele. The same interaction is presumed to lead to sterility, by mutual spermatozoa destruction, in tit mice. This interaction implies the occurrence of a chromosome 17-coded, spermatozoa-specific, signaling interaction that is remarkably reminiscent of the signaling role of ALR, and other hepatotropic factors, in hepatocyte survival and proliferation. It might also be speculated that this same mechanism of cellular interaction might account for some of the effects of mutant t-alleles in embryonic development, thus leading to their lethal phenotypes.
Although a number of candidate T/t-region gene products that are expressed in the testes have been identified, none have been able to account completely for these signaling effects of T/t-region alleles. In this regard, it is of great interest that we have found ALR mRNA to be strongly expressed in the testes, and immunofluorescence studies have revealed that the ALR protein is located within the germ cells of the mouse testes (Chyung, Kang, Rao, Starzl, and Michaelson, in preparation). Thus, it is clear that ALR must also be considered a candidate gene product that may account for some of the fascinating phenotypic effects of the Tlt region, in both embryonic development and sperm function.
